Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Meglumine manufacturers

7 products found

Filters

7 products found

tafamidis + meglumine

Oral solution 10 mg/ml , 20 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #31060
This company is a contract development and manufacturing organization (CDMO) specializing in the production of high-potency and oncological oral liquid formulations. Established in recent years, the company operates primarily in the European Union and North America. Their core expertise lies in developing and manufacturing customized, high-quality, and cost-effective oral liquid products for patients requiring dose titration and tailored treatment plans. Their production lines focus on oncology, specifically targeting high-potency medications for oral administration. This CDMO has a strong emphasis on quality, with a state-of-the-art facility and robust quality systems. Their services encompass the entire drug development process from formulation and analytical development to clinical trials, regulatory support, and commercial manufacturing. This company is actively expanding its GMP-approved manufacturing facilities and strives to provide a full range of services to support partners in overcoming the unique challenges of developing high-potency oral liquid formulations.

Manufacturer usually replies in 86 days

meglumine

Injection 1.5 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20110
This pharmaceutical contract manufacturer specializes in a wide range of dosage forms including tablets, capsules, injections, syrups, suspensions, and eye/ear drops. They operate across numerous key regions globally, with a strong presence in Africa, Asia Pacific, North America, and the EU. Their expertise spans several therapy areas such as generics, rare diseases, nutraceuticals, and functional ingredients. The company boasts several patented products and holds GMP certifications, ensuring high-quality manufacturing standards. They are known for their commitment to research and development, constantly innovating with new ingredients like Fibronectin for wound healing.

Manufacturer usually replies in 8 days

diatrizoate sodium + meglumine

Injection 76 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Established in 2004, this vertically integrated pharmaceutical manufacturer is committed to delivering high-quality, affordable medicines globally. As a CTD dossier owner and manufacturer, it holds GMP certifications from the US FDA, EU, and WHO, ensuring compliance with stringent international quality standards. The company's state-of-the-art R&D center is capable of handling oral solids, liquids, and parenteral formulations. Its products have received marketing authorizations from regulatory authorities such as the US FDA, Health Canada, CDSCO-India, and New Zealand. With over 20 ANDA/ANDs under approval, the manufacturer operates advanced production lines adhering to rigorous GMP guidelines. Its diverse portfolio includes therapeutics in areas like antivirals, neurology, women's health, cardiology, and imaging contrast agents.

Manufacturer usually replies in 8 days

Want to see all 7 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible